U.S. - Medicaments Containing Hormones But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
Report Update: Feb 1, 2026

U.S. - Medicaments Containing Hormones But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights

Single report
Sent by email within 24h (Mon-Fri)
Subscription
Online access and download
from $140/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Medicaments Containing Hormones Prices in the United States

U.S. Medicaments Containing Hormones Export Price per Ton in June 2022

In June 2022, the medicaments containing hormones price per ton stood at $565.0K (FOB, US), reducing by -4.5% against the previous month. Over the period under review, the export price, however, showed significant growth. The most prominent rate of growth was recorded in March 2022 when the average export price increased by 125% month-to-month. The export price peaked at $591.6K per ton in May 2022, and then shrank slightly in the following month.

Prices varied noticeably by the country of destination: the country with the highest price was Switzerland ($18.5M per ton), while the average price for exports to Mexico ($1.9K per ton) was amongst the lowest.

From January 2022 to June 2022, the most notable rate of growth in terms of prices was recorded for supplies to Denmark (+151.9%), while the prices for the other major destinations experienced more modest paces of growth.

U.S. Medicaments Containing Hormones Exports

For the third consecutive month, the United States recorded growth in shipments abroad of medicaments containing hormones but not antibiotics, which increased by 226% to 153 tons in July 2022. Overall, exports saw buoyant growth.

In value terms, medicaments containing hormones exports contracted dramatically to $16M (IndexBox estimates) in July 2022. Over the period under review, exports enjoyed a resilient increase. The pace of growth appeared the most rapid in May 2022 with an increase of 191% m-o-m.

U.S. Medicaments Containing Hormones Exports by Country

Mexico (42 tons) was the main destination for medicaments containing hormones exports from the United States, with a 89% share of total exports. Moreover, medicaments containing hormones exports to Mexico exceeded the volume sent to the second major destination, the UK (1.6 tons), more than tenfold. Canada (1.4 tons) ranked third in terms of total exports with a 3% share.

From January 2022 to June 2022, the average monthly growth rate of volume to Mexico stood at +16.8%. Exports to the other major destinations recorded the following average monthly rates of exports growth: the UK (+340.0% per month) and Canada (-2.5% per month).

In value terms, Switzerland ($21M) remains the key foreign market for medicaments containing hormones exports from the United States, comprising 79% of total exports. The second position in the ranking was held by the UK ($500K), with a 1.9% share of total exports. It was followed by Canada, with a 1.3% share.

From January 2022 to June 2022, the average monthly rate of growth in terms of value to Switzerland amounted to +45.8%. Exports to the other major destinations recorded the following average monthly rates of exports growth: the UK (+182.0% per month) and Canada (+5.6% per month).

Source: IndexBox Market Intelligence Platform

This report provides an in-depth analysis of the medicaments containing hormones market in the U.S.. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201250 - Medicaments containing hormones but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale (excluding insulin)

Country coverage:

    Data coverage:

    • Market volume and value
    • Per Capita consumption
    • Forecast of the market dynamics in the medium term
    • Trade (exports and imports) in the U.S.
    • Export and import prices
    • Market trends, drivers and restraints
    • Key market players and their profiles

    Reasons to buy this report:

    • Take advantage of the latest data
    • Find deeper insights into current market developments
    • Discover vital success factors affecting the market

    This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

    In this report, you can find information that helps you to make informed decisions on the following issues:

    1. How to diversify your business and benefit from new market opportunities
    2. How to load your idle production capacity
    3. How to boost your sales on overseas markets
    4. How to increase your profit margins
    5. How to make your supply chain more sustainable
    6. How to reduce your production and supply chain costs
    7. How to outsource production to other countries
    8. How to prepare your business for global expansion

    While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

    1. 1. INTRODUCTION

      Making Data-Driven Decisions to Grow Your Business

      1. REPORT DESCRIPTION
      2. RESEARCH METHODOLOGY AND THE AI PLATFORM
      3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
      4. GLOSSARY AND SPECIFIC TERMS
    2. 2. EXECUTIVE SUMMARY

      A Quick Overview of Market Performance

      1. KEY FINDINGS
      2. MARKET TRENDSThis Chapter is Available Only for the Professional EditionPRO
    3. 3. MARKET OVERVIEW

      Understanding the Current State of The Market and its Prospects

      1. MARKET SIZE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
      2. MARKET STRUCTURE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
      3. TRADE BALANCE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
      4. PER CAPITA CONSUMPTION: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
      5. MARKET FORECAST TO 2035
    4. 4. MOST PROMISING PRODUCTS FOR DIVERSIFICATION

      Finding New Products to Diversify Your Business

      1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
      2. BEST-SELLING PRODUCTS
      3. MOST CONSUMED PRODUCTS
      4. MOST TRADED PRODUCTS
      5. MOST PROFITABLE PRODUCTS FOR EXPORTS
    5. 5. MOST PROMISING SUPPLYING COUNTRIES

      Choosing the Best Countries to Establish Your Sustainable Supply Chain

      1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
      2. TOP PRODUCING COUNTRIES
      3. TOP EXPORTING COUNTRIES
      4. LOW-COST EXPORTING COUNTRIES
    6. 6. MOST PROMISING OVERSEAS MARKETS

      Choosing the Best Countries to Boost Your Export

      1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
      2. TOP CONSUMING MARKETS
      3. UNSATURATED MARKETS
      4. TOP IMPORTING MARKETS
      5. MOST PROFITABLE MARKETS
    7. 7. PRODUCTION

      The Latest Trends and Insights into The Industry

      1. PRODUCTION VOLUME AND VALUE: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
    8. 8. IMPORTS

      The Largest Import Supplying Countries

      1. IMPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
      2. IMPORTS BY COUNTRY: HISTORICAL DATA (2012–2024)
      3. IMPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024)
    9. 9. EXPORTS

      The Largest Destinations for Exports

      1. EXPORTS: HISTORICAL DATA (2012–2024) AND FORECAST (2025–2035)
      2. EXPORTS BY COUNTRY: HISTORICAL DATA (2012–2024)
      3. EXPORT PRICES BY COUNTRY: HISTORICAL DATA (2012–2024)
    10. 10. PROFILES OF MAJOR PRODUCERS

      The Largest Producers on The Market and Their Profiles

    11. LIST OF TABLES

      1. Key Findings In 2024
      2. Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
      3. Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
      4. Per Capita Consumption: Historical Data (2012–2024) and Forecast (2025–2035)
      5. Imports, In Physical Terms, By Country, 2012–2024
      6. Imports, In Value Terms, By Country, 2012–2024
      7. Import Prices, By Country, 2012–2024
      8. Exports, In Physical Terms, By Country, 2012–2024
      9. Exports, In Value Terms, By Country, 2012–2024
      10. Export Prices, By Country, 2012–2024
    12. LIST OF FIGURES

      1. Market Volume, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
      2. Market Value: Historical Data (2012–2024) and Forecast (2025–2035)
      3. Market Structure – Domestic Supply vs. Imports, in Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
      4. Market Structure – Domestic Supply vs. Imports, in Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
      5. Trade Balance, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
      6. Trade Balance, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
      7. Per Capita Consumption: Historical Data (2012–2024) and Forecast (2025–2035)
      8. Market Volume Forecast to 2035
      9. Market Value Forecast to 2035
      10. Market Size and Growth, By Product
      11. Average Per Capita Consumption, By Product
      12. Exports and Growth, By Product
      13. Export Prices and Growth, By Product
      14. Production Volume and Growth
      15. Exports and Growth
      16. Export Prices and Growth
      17. Market Size and Growth
      18. Per Capita Consumption
      19. Imports and Growth
      20. Import Prices
      21. Production, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
      22. Production, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
      23. Imports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
      24. Imports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
      25. Imports, In Physical Terms, By Country, 2024
      26. Imports, In Physical Terms, By Country, 2012–2024
      27. Imports, In Value Terms, By Country, 2012–2024
      28. Import Prices, By Country, 2012–2024
      29. Exports, In Physical Terms: Historical Data (2012–2024) and Forecast (2025–2035)
      30. Exports, In Value Terms: Historical Data (2012–2024) and Forecast (2025–2035)
      31. Exports, In Physical Terms, By Country, 2024
      32. Exports, In Physical Terms, By Country, 2012–2024
      33. Exports, In Value Terms, By Country, 2012–2024
      34. Export Prices, By Country, 2012–2024
    Store
    Blog
    Event
    U.S. - Medicaments Containing Hormones But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
    $599
    Feb 1, 2026
    Eye 317

    This report provides an in-depth analysis of the medicaments containing hormones market in the U.S..

    U.S. - Other Medicaments For Therapeutic Or Prophylactic Uses - Market Analysis, Forecast, Size, Trends And Insights
    $599
    Feb 1, 2026
    Eye 246

    This report provides an in-depth analysis of the market for other medicaments for therapeutic or prophylactic uses in the U.S..

    U.S. - Medicaments Of Alkaloids Or Derivatives Thereof - Market Analysis, Forecast, Size, Trends And Insights
    $599
    Feb 1, 2026
    Eye 154

    This report provides an in-depth analysis of the market for medicaments of alkaloids or derivatives thereof in the U.S..

    U.S. - Medicaments Of Other Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
    $599
    Feb 1, 2026
    Eye 153

    This report provides an in-depth analysis of the market for medicaments of other antibiotics in the U.S..

    U.S. - Medicaments Containing Insulin But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
    $599
    Feb 1, 2026
    Eye 334

    This report provides an in-depth analysis of the medicaments containing insulin market in the U.S..

    U.S. - Medicaments Containing Penicillins Or Derivatives Thereof - Market Analysis, Forecast, Size, Trends And Insights
    $599
    Feb 1, 2026
    Eye 340

    This report provides an in-depth analysis of the medicaments containing penicillin market in the U.S..

    World - Medicaments Containing Hormones But Not Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
    $599
    Feb 1, 2026
    Eye 382

    This report provides an in-depth analysis of the global medicaments containing hormones market.

    World - Other Medicaments For Therapeutic Or Prophylactic Uses - Market Analysis, Forecast, Size, Trends And Insights
    $599
    Feb 1, 2026
    Eye 263

    This report provides an in-depth analysis of the global market for other medicaments for therapeutic or prophylactic uses.

    World - Medicaments Of Alkaloids Or Derivatives Thereof - Market Analysis, Forecast, Size, Trends And Insights
    $599
    Feb 1, 2026
    Eye 330

    This report provides an in-depth analysis of the global market for medicaments of alkaloids or derivatives thereof.

    World - Medicaments Of Other Antibiotics - Market Analysis, Forecast, Size, Trends And Insights
    $599
    Feb 1, 2026
    Eye 207

    This report provides an in-depth analysis of the global market for medicaments of other antibiotics.

    Eli Lilly Exceeds Earnings Expectations, Ups 2025 Guidance
    Feb 6, 2025
    Eye 90

    Eli Lilly reports strong Q4 2024 earnings, boosts 2025 guidance; driven by impressive GLP-1 drug sales, it remains an attractive investment opportunity.

    Exploring the World's Leading Import Markets for Medicaments Containing Hormones
    Sep 3, 2024
    Eye 152

    Discover the top import markets for medicaments containing hormones, including Belgium, Denmark, United States, and more. Learn about the key players in the global market for hormone medications.

    The Largest Import Markets for Non-Antibiotic Medicaments
    Apr 22, 2024
    Eye 293

    Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.

    Best Import Markets for Non-Penicillin or Streptomycin Antibiotic Medicaments
    Jul 16, 2024
    Eye 216

    Discover the top countries by import value of non-penicillin or streptomycin antibiotic medicaments in 2023. Explore key statistics and market insights.

    Pharmaceutical Giants Compete in Obesity Drug Market
    Dec 23, 2024
    Eye 262

    Pharmaceutical companies are fiercely competing in the obesity drug market, with Eli Lilly and Novo Nordisk among the major players. Innovations and collaborations are key in this dynamic and lucrative sector.

    Novo Holdings to Finalize $16.5 Billion Acquisition of Catalent
    Dec 14, 2024
    Eye 201

    Novo Holdings finalizes $16.5 billion acquisition of Catalent, enhancing pharmaceutical capabilities amidst regulatory clearance.

    Eli Lilly Exceeds Earnings Expectations, Ups 2025 Guidance
    Feb 6, 2025
    Eye 90

    Eli Lilly reports strong Q4 2024 earnings, boosts 2025 guidance; driven by impressive GLP-1 drug sales, it remains an attractive investment opportunity.

    Exploring the World's Leading Import Markets for Medicaments Containing Hormones
    Sep 3, 2024
    Eye 152

    Discover the top import markets for medicaments containing hormones, including Belgium, Denmark, United States, and more. Learn about the key players in the global market for hormone medications.

    The Largest Import Markets for Non-Antibiotic Medicaments
    Apr 22, 2024
    Eye 293

    Explore the top 10 import markets for non-antibiotic, non-hormone, non-alkaloid medicaments based on the latest data. Discover the key countries driving the demand for therapeutic and prophylactic medicaments.

    Best Import Markets for Non-Penicillin or Streptomycin Antibiotic Medicaments
    Jul 16, 2024
    Eye 216

    Discover the top countries by import value of non-penicillin or streptomycin antibiotic medicaments in 2023. Explore key statistics and market insights.

    Free Data: Medicaments Containing Hormones But Not Antibiotics - United States